ArticleCureus2025
Proteinuria With Functionally Normal Kidneys: A Hidden Clue to the Diagnosis of Diffuse Large B-cell Lymphoma (DLBCL) With Secondary Glomerular Infiltration.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse large B-cell lymphoma (DLBCL) is an aggressive, rapidly progressive type of non-Hodgkin lymphoma that arises from mature B lymphocytes and is characterized by diffuse involvement of lymph nodes as well as possible extranodal tissues. It typically presents with fever, night sweats, weight loss and lymph node enlargement. While extranodal organ involvement is relatively common, the renal involvement remains a rare and under-recognized manifestation. We report the case of a 66-year-old female patient initially admitted with lower respiratory tract infection (LRTI), who was later diagnosed with DLBCL involving the kidneys. The fever began a week before admission, and despite receiving appropriate treatment for LRTI, she continued to spike intermittent fevers. Clinical assessment revealed pedal oedema, hypoalbuminemia and nephrotic range proteinuria, with preserved renal function. A fluorodeoxyglucose positron emission tomography (FDG PET) scan demonstrated metabolically active cervical lymphadenopathy, and subsequent biopsies of kidney and cervical lymph node confirmed the diagnosis of DLBCL. Timely initiation of the polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisolone (Pola-R-CHP) chemotherapy regimen led to significant clinical improvement within six weeks of diagnosis. This case highlights the importance of recognizing renal involvement in atypical presentations of DLBCL, emphasizing the need for clinical vigilance to facilitate early diagnosis, timely management, and improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.